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deacetylase inhibitor molecule
tinostamustine shows antitumor effects
and is synergistic with radiotherapy in
preclinical models of glioblastoma
C. Festuccia1*, A. Mancini2, A. Colapietro2, G. L. Gravina2,3, F. Vitale4, F. Marampon3, S. Delle Monache5, S. Pompili6,
L. Cristiano7, A. Vetuschi6, V. Tombolini8, Y. Chen9 and T. Mehrling10Erratum
The original article [1] contained an error whereby
Fig. 4 displayed incorrect magnification scales.
This has now been corrected, and can be seen ahead
and in the original article [1].
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Fig. 4 Morphological and functional effects of TINO when combined with RT in glioma cell lines. a Morphological changes observed in U251
cells after treatments with 2, 4, and 6 Gy (RT) alone or in association with TINO 3.5 μM. b Morphological changes observed in U87MG cells after
treatments with 2, 4, and 6 Gy (RT) alone or in association with TINO 3.5 μM. c Representative expression of acidic vacuolar organelle (AVO)
accumulation in T98G cells cultured with 2, 4, and 6 Gy (RT) alone or in association with TINO 3.5 μM. d Percentage of AVO-stained cells in
U87MG, U251, and T98G cells cultured with 2, 4, and 6 Gy (RT) alone or in association with TINO 3.5 μM. Statistical analysis: *p < 0.005 in the
comparison between combined TINO + RT treatment and RT alone. Single results are representative of three different experiments performed in
triplicate. e Immunocytochemical evaluation of γH2Ax stain in T98G cells cultured with 4, 6, and 8 Gy (RT) alone or in association with TINO 3.5
μM. f Quantization of γH2AX expression in U87MG, U251, and T98G cells treated with RT with or without TINO. Statistical analyses: *p < 0.005 in
the comparison between RT + TINO and RT or TINO treatments alone. Single results are representative of three different experiments performed
in triplicate
Festuccia et al. Journal of Hematology & Oncology  (2018) 11:38 Page 2 of 2
